TREATMENT OF TUBERCULOUS SPONDYLITIS IN PATIENTS WITH A HISTORY OF VIRAL HEPATITIS
Abstract
Tuberculous spondylitis is one of the most severe forms of extrapulmonary tuberculosis, characterized by progressive destruction of the vertebrae, spinal deformities, and the development of neurological complications. The treatment of tuberculous spondylitis in patients with a prior history of viral hepatitis represents a particular clinical challenge, since standard anti-tuberculosis therapy regimens are hepatotoxic and may lead to reactivation or decompensation of chronic liver damage.
References
Liu Y.M., Cheng Y.J., Li Y.L. Antituberculosis treatment and hepatotoxicity in patients with chronic viral hepatitis — analysis of the impact of anti-tuberculosis therapy on the development of drug-induced hepatitis in individuals with chronic viral hepatitis.
Chou C., Veracruz N., Chitnis A.S., Wong R.J. Risk of drug-induced liver injury in chronic hepatitis B and tuberculosis co-infection: A systematic review and meta-analysis — systematic review of the risk of drug-induced liver injury in patients with HBV and tuberculosis co-infection.
Ashkin A., Alexis A., Ninneman M. Concomitant Treatment of Tuberculosis and Hepatitis C Virus in Coinfected Patients Using Serum Drug Concentration Monitoring — approaches to simultaneous treatment of tuberculosis and hepatitis C with drug concentration monitoring.
Kizilbash Q.F., Seaworth B.J. Multi-drug resistant tuberculous spondylitis: A review of the literature — review of treatment principles for multidrug-resistant tuberculous spondylitis.
